Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center
UEI LTJVF4QSFCP9 · CA · SAM.gov record ↗
$113K
FY2025 obligations
5
Contract awards
Sep 13, 2015
First action
Jun 30, 2026
Latest action
Obligations by agency
- Department Of Veterans Affairs$77K
- Department Of Health And Human Services$36K
Obligations by NAICS
Monthly obligations
Aug 25
Sep 25
Dec 25
Jun 26
Jul 26
Contracts ending within 18 months (recompete watch)
- 36C24E25N0266 ↗$77K
RESEARCH LAB DNA
- Ends
- Sep 20, 2026
- Started
- Sep 21, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541713
- 75N94020F00001 ↗$36K
NICHD: R&D: CORE FUNCTION ACTIVITIES: SEVERABLE
- Ends
- Sep 26, 2026
- Started
- Sep 27, 2020
- Agency
- National Institutes Of Health
- NAICS
- 541714
NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
- Ends
- Dec 30, 2026
- Started
- Sep 13, 2015
- Agency
- National Institutes Of Health
- NAICS
- 541711
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C24E25N0266 ↗ | RESEARCH LAB DNA | Department Of Veterans Affairs | 541713 | $77K | Sep 21, 2025 | Sep 20, 2026 |
| 75N94020F00001 ↗ | NICHD: R&D: CORE FUNCTION ACTIVITIES: SEVERABLE | National Institutes Of Health | 541714 | $36K | Sep 27, 2020 | Sep 26, 2026 |
| HHSN27500007 ↗ | NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | National Institutes Of Health | 541711 | $0 | Sep 13, 2015 | Dec 30, 2026 |
Largest awards
- 36C24E25N0266 ↗$77K
RESEARCH LAB DNA
- Ends
- Sep 20, 2026
- Started
- Sep 21, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541713
- 75N94020F00001 ↗$36K
NICHD: R&D: CORE FUNCTION ACTIVITIES: SEVERABLE
- Ends
- Sep 26, 2026
- Started
- Sep 27, 2020
- Agency
- National Institutes Of Health
- NAICS
- 541714
NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
- Ends
- Dec 30, 2026
- Started
- Sep 13, 2015
- Agency
- National Institutes Of Health
- NAICS
- 541711
RESEARCH SERVICES DNA
- Ends
- —
- Started
- Sep 21, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 541713
EO14398 NICHD: R&D: CONTRACEPTIVE DEVELOPMENT PROGRAM NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK - MALE SITES: SEVERABLE
- Ends
- —
- Started
- Sep 27, 2020
- Agency
- National Institutes Of Health
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C24E25N0266 ↗ | RESEARCH LAB DNA | Department Of Veterans Affairs | 541713 | $77K | Sep 21, 2025 | Sep 20, 2026 |
| 75N94020F00001 ↗ | NICHD: R&D: CORE FUNCTION ACTIVITIES: SEVERABLE | National Institutes Of Health | 541714 | $36K | Sep 27, 2020 | Sep 26, 2026 |
| HHSN27500007 ↗ | NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | National Institutes Of Health | 541711 | $0 | Sep 13, 2015 | Dec 30, 2026 |
| 36C24E25D0038 ↗ | RESEARCH SERVICES DNA | Department Of Veterans Affairs | 541713 | $0 | Sep 21, 2025 | — |
| 75N94020D00007 ↗ | EO14398 NICHD: R&D: CONTRACEPTIVE DEVELOPMENT PROGRAM NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK - MALE SITES: SEVERABLE | National Institutes Of Health | 541714 | $0 | Sep 27, 2020 | — |